Published in Gene Therapy Weekly, August 21st, 2008
"Although lapatinib showed significant activity in patients with HER2-positive breast cancer, the role of EGFR in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.